Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
8427 items from SEC EDGAR · clear filters
- 8-K - TYSON FOODS, INC. (0000100493) (Filer)
Automated noteTyson Foods, Inc. filed a Form 8-K with the SEC on September 3, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and related exhibits (Item 9.01).
- 8-K - CYABRA, INC. (0002032341) (Filer)
Automated noteCyabra, Inc. filed a Form 8-K reporting director/officer departures and appointments, related compensation arrangements, a shareholder vote, and accompanying financial statements and exhibits.
- 8-K - JOHN WILEY & SONS, INC. (0000107140) (Filer)
Automated noteJohn Wiley & Sons, Inc. filed an 8-K on September 3, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching its financial statements and related exhibits.
- 8-K - FARADAY FUTURE INTELLIGENT ELECTRIC INC. (0001805521) (Filer)
Automated noteFaraday Future Intelligent Electric Inc. filed a Form 8-K on September 3 2026, reporting entry into a material definitive agreement, providing a Regulation FD disclosure, and including financial statements and related exhibits.
- 8-K - MediaAlpha, Inc. (0001818383) (Filer)
Automated noteMediaAlpha, Inc. filed a Form 8-K on September 3 2026 reporting director and officer departures and appointments, related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - CarGurus, Inc. (0001494259) (Filer)
Automated noteCarGurus, Inc. filed a Form 8-K reporting director and officer departures, appointments and related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Apogee Therapeutics, Inc. (0001974640) (Filer)
Automated noteApogee Therapeutics filed an 8-K reporting termination of a material definitive agreement, completion of an acquisition, a delisting notice and listing transfer, material modifications to security-holder rights, changes in control, and departures of directors and officers.
- 8-K - AbbVie Inc. (0001551152) (Filer)
Automated noteAbbVie Inc. filed a Form 8-K with the SEC on September 3, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and related exhibits (Item 9.01).
- 8-K - HF Foods Group Inc. (0001680873) (Filer)
Automated noteHF Foods Group Inc. filed a Form 8-K reporting the completion of an acquisition, the creation of a direct financial obligation, and accompanying financial statements and exhibits.
- 8-K - Eightco Holdings Inc. (0001892492) (Filer)
Automated noteEightco Holdings Inc. filed an 8-K with the SEC on September 3, 2026, containing a Regulation FD disclosure (Item 7.01) and financial statements and related exhibits (Item 9.01).
- 8-K - TORO CO (0000737758) (Filer)
Automated noteToro Co (CIK 0000737758) filed a Form 8-K on September 3, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - SurgePays, Inc. (0001392694) (Filer)
Automated noteSurgePays, Inc. filed a Form 8-K with the SEC on September 3, 2026, reporting an Item 8.01 “Other Events” disclosure (Accession No. 0001493152-26-041325, 201 KB).
- 8-K - Alaska Silver Corp. (0001893899) (Filer)
Automated noteAlaska Silver Corp filed a Form 8-K on September 3, 2026 reporting departures and appointments of directors and officers, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Aptevo Therapeutics Inc. (0001671584) (Filer)
Automated noteAptevo Therapeutics Inc. filed a Form 8-K with the SEC on September 3, 2026 (Accession No. 0001193125-26-381098), containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - CXApp Inc. (0001820875) (Filer)
Automated noteCXApp Inc. filed a Form 8-K reporting a notice of delisting or failure to satisfy a continued listing rule and a transfer of listing, together with a Regulation FD disclosure and related financial statements and exhibits.
- 8-K - LB PHARMACEUTICALS INC (0001691082) (Filer)
Automated noteLB Pharmaceuticals filed a Form 8-K reporting departures and appointments of directors and officers, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - NVIDIA CORP (0001045810) (Filer)
Automated noteNVIDIA Corp filed a Form 8-K under Item 8.01 (Other Events) with the SEC on September 3, 2026 (Accession No. 0001045810-26-000078).
- 8-K - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)
Automated noteJupiter Neurosciences, Inc. filed a Form 8-K on September 3, 2026, reporting amendments to its articles of incorporation or bylaws and a change in its fiscal year, and providing accompanying financial statements and related exhibits.
- 8-K - Aimei Health Technology Co., Ltd. (0001979005) (Filer)
Automated noteAimei Health Technology Co., Ltd. filed a Form 8-K on September 3, 2026, reporting the creation of a direct financial obligation/off-balance-sheet arrangement and providing its financial statements and related exhibits.
- 8-K - Liquidia Corp (0001819576) (Filer)
Automated noteLiquidia Corp filed a Form 8-K on September 3, 2026, reporting other events under Item 8.01 and providing its financial statements and related exhibits under Item 9.01.
- 8-K - Medicus Pharma Ltd. (0001997296) (Filer)
Automated noteMedicus Pharma Ltd. filed a Form 8-K on September 3, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.
- 8-K - Climb Bio, Inc. (0001768446) (Filer)
Automated noteClimb Bio, Inc. filed a Form 8-K on September 3 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - EQUITY BANCSHARES INC (0001227500) (Filer)
Automated noteEquity Bancshares filed a Form 8-K on September 3, 2026, reporting an entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Hillman Solutions Corp. (0001822492) (Filer)
Automated noteHillman Solutions Corp. filed a Form 8-K on September 3, 2026 reporting entry into a material definitive agreement, completion of an acquisition or asset disposition, other events, and accompanying financial statements and exhibits.
- 8-K - SAIA INC (0001177702) (Filer)
Automated noteSaia Inc. filed a Form 8-K on September 3, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Crown PropTech Acquisitions (0001827899) (Filer)
Automated noteCrown PropTech Acquisitions filed a Form 8-K on September 3, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits (Accession No. 0001213900-26-096929).
- 8-K - DULUTH HOLDINGS INC. (0001649744) (Filer)
Automated noteDuluth Holdings Inc. filed a Form 8-K on September 3, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and exhibits.
- 8-K - CAMPBELL'S Co (0000016732) (Filer)
Automated noteCampbell's Co filed a Form 8-K on September 3, 2026, including Item 2.02 covering results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - GENESCO INC (0000018498) (Filer)
Automated noteGinesco Inc filed a Form 8-K on September 3, 2026, containing Item 2.02 results of operations and financial condition and Item 9.01 financial statements and exhibits.
- 8-K - CIENA CORP (0000936395) (Filer)
Automated noteCiena Corp filed a Form 8-K on September 3, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.